Introduction
A blank shaded cell in the table indicates that the questionnaire topic, measure or lab test listed under the subject column is not included in the corresponding collection cycle. In the tables, the cell indicates the age ranges for which the questionnaire topic, measure or lab test is applicable.
When combining or comparing data between cycles, see the most recent instruction document for combining CHMS data, as well as the Data Dictionary and User Guide for information and relevant procedures.
Type Legend
- PM Physical Measure
- Q Questionnaire
- S Sample
- SC Specimen Collection
Matrix Legend
- B Blood
- U Urine
- S Saliva
- H Hair
- IAS Indoor Air Sampler
- TWS Tap Water Sampler
Theme | Module | Type | Cycle 1 2007-2009 | Cycle 2 2009-2011 | Cycle 3 2012-2013 | Cycle 4 2014-2015 | Cycle 5 2016-2017 | Cycle 6 2018-2019 |
---|---|---|---|---|---|---|---|---|
Age (years) | ||||||||
Alcohol | Alcohol use | Q | 12-79 | 12-79 | 12-79 | 12-79 | 12-79 | 12-79 |
Anthropometry | Height and weight (self report) | Q | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Weight change | Q | 18-79 | 18-79 | |||||
Chronic conditions | Chronic conditions | Q | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
PhlegmFootnote 10 | Q | 6-79 | 3-79 | 3-79 | 3-79 | |||
Drug/Medication use | Illicit drug use | Q | 14-79 | 14-79 | 14-79 | 14-79 | 14-79 | 14-79 |
Medication useFootnote 1 | Q | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 | 1-79 |
Environmental exposure | Grooming product useFootnote 2 | Q | 6-79 | |||||
Hobbies | Q | 6-79 | 3-79 | 3-79 | 3-79 | |||
Housing characteristicsFootnote 3 | Q | 6-79 | 3-79 | 1-79 | ||||
Tap water collectionFootnote 8 | S | Data at Household Level | Data HHLD Level | |||||
Family medical history | Family medical history | Q | 6-79 | 3-79 | 3-79 | 3-79 | ||
General health | General health | Q | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Health utility index | Q | 6-79 | 6-79 | 6-79 | 6-79 | |||
Strengths and difficultiesFootnote 4 | Q | 6-17 | 6-17 | 4-17 | 4-17 | 4-17 | ||
Infection markers | Hepatitis | Q | 6-79 | 3-79 | 3-79 | 3-79 | ||
Human papillomavirus vaccine | Q | 9-39 | 9-59 | |||||
Toxoplasmosis | Q | 3-79 | ||||||
Musculoskeletal health | Bone health- Medication | Q | 3-79 | 3-79 | ||||
Bone health- Menopause | Q | 40-65 (F) | 40-65 (F) | 40-65 (F) | ||||
Fracture history | Q | 3-79 | 3-79 | 1-79 | ||||
Nutrition | Dietary fat consumption | Q | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Grains, fruits and vegetables consumption | Q | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Meat and fish consumptionFootnote 5 | Q | 6-79 | ||||||
Meat consumptionFootnote 5 | Q | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 | |
Milk & Dairy consumption | Q | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Salt consumption | Q | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Water & soft drink consumption | Q | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Oral health | Oral health | Q | 6-79 | |||||
Physical activity | Children's physical activity | Q | 6-11 | 3-11 | 3-11 | 3-11 | 3-11 | 3-11 |
International physical activityFootnote 6 | Q | 12-79 | ||||||
Physical activities (PAC)Footnote 7 | Q | 12-79 | 12-79 | |||||
Physical Activities for Youth | Q | 12-17 | 12-17 | 12-17 | 12-17 | |||
Physical Activities-Adults | Q | 18-79 | 18-79 | 18-79 | 18-79 | |||
Sedentary activities | Q | 12-79 | 12-79 | 12-79 | 12-79 | 12-79 | 12-79 | 3-79 |
Time spent outdoors | Q | 3-14 | 3-14 | 3-79 | 3-79 | |||
Neighbourhood environment | Q | 3-79 | 3-79 | |||||
Pregnancy/Birth | Birth Control | Q | 12-79 | 12-79 | ||||
Birth information | Q | 6-11 | 3-11 | 3-11 | 3-11 | 3-11 | 3-11 | 1-11 |
Breastfeeding | Q | 14-79 | 14-79 | 14-79 | ||||
Breastfeeding information | Q | 6-11 | 3-11 | 3-11 | 3-11 | 3-11 | 3-11 | 1-11 |
Maternal breastfeeding | Q | 14-79 | 14-79 | 14-79 | 14-79 | 14-79 | ||
Pregnancy | Q | 14-59 | 14-59 | 14-59 | 14-59 | 14-59 | 14-59 | 14-59 |
Pregnancy information | Q | 6-11 | 3-11 | 3-11 | 3-11 | 3-11 | 3-11 | 1-11 |
Sexual health | Pap smear test | Q | 14-79 | 14-79 | ||||
Sexual behaviour | Q | 14-79 | 14-79 | 14-79 | 14-79 | 14-79 | 14-79 | 14-79 |
Sleep | Sleep apnea | Q | 18-79 | 18-79 | ||||
Sleep | Q | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | ||
Smoking | Electronic Cigarette | Q | 12-79 | 12-79 | ||||
Exposure to second-hand smoke | Q | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 | 1-79 |
Exposure to second-hand vapor | Q | 3-79 | 3-79 | 1-79 | ||||
Smoking | Q | 12-79 | 12-79 | 12-79 | 12-79 | 12-79 | 12-79 | 12-79 |
Socio-demographic characteristics | Education | Q | 15-79 | 15-79 | 12-79 | 3-79 | 3-79 | 3-79 |
Income | Q | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 | 1-79 |
Labour force activity | Q | 15-75 | 15-75 | 15-75 | 15-75 | 15-75 | 15-75 | 15-75 |
Socio-demographic characteristics | Q | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 | 1-79 |
Language Extended | Q | 3-79 | 3-79 | 3-79 | 3-79 | 1-79 | ||
Vision | Vision Household | Q | 3-79 | 3-79 | ||||
Vision PrescriptionFootnote 9 | Q | 6-79 | ||||||
Vitamin D | Sun Exposure | Q | 6-79 | 3-79 | ||||
(F) = Females
|
Theme | Subject | Type | Cycle 1 2007-2009 | Cycle 2 2009-2011 | Cycle 3 2012-2013 | Cycle 4 2014-2015 | Cycle 5 2016-2017 | Cycle 6 2018-2019 |
---|---|---|---|---|---|---|---|---|
Age (years) | ||||||||
Anthropometry | Standing height | PM | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Recumbent length | PM | 1 | ||||||
Sitting height | PM | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | ||
Weight | PM | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 | 1-79 |
Skinfolds | PM | 6-79 | 3-79 | |||||
Waist circumferenceFootnote 1 | PM | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Hip circumference | PM | 6-79 | 3-79 | 3-79 | 3-79 | |||
Neck circumference | PM | 3-19 | 3-79 | 3-79 | ||||
Cardiovascular health and fitness | Blood pressure (resting) | PM | 6-79Footnote 11 | 6-79Footnote 11 | 6-79Footnote 11 | 6-79Footnote 11 | 6-79Footnote 11 | 6-79Footnote 11,Footnote 12 |
Heart rate (resting) | PM | 6-79Footnote 11 | 6-79Footnote 11 | 6-79Footnote 11 | 6-79Footnote 11 | 6-79Footnote 11 | 6-79Footnote 11, Footnote 12 | 6-79Footnote 13 |
Modified Canadian Aerobic Fitness Test (mCAFT step test) | PM | 6-69 | 8-69 | 8-69 | 8-69 | |||
Drug/Medication use | Medication useFootnote 2 | Q | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Environmental exposure | Grooming product useFootnote 3 | Q | 3-79 | |||||
Indoor air Questions + SamplerFootnote 4 | Q + S | Data at Household Level | ||||||
Water Analysis QuestionsFootnote 5 | Q | Data at Household Level | Data at Household Level | |||||
Hearing | Hearing ability | Q | 3-79 | 3-79 | ||||
Noise exposure | Q | 3-79 | 3-79 | |||||
Otoscopy | PM | 3-79 | 3-79 | |||||
Tympanometry | PM | 3-79 | 3-79 | |||||
Otoacoustic Emissions | PM | 3-79 | 3-79 | |||||
Audiometry | PM | 6-79 | 6-79 | |||||
Lung health | Fractional Exhaled Nitric Oxide | PM | 6-79 | |||||
Spirometry | PM | 6-79 | 6-79 | 6-79 | 6-79 | |||
Musculoskeletal fitness | Hand grip strength | PM | 6-79 | 6-79 | 6-79 | 6-79 | 6-79 | 6-79 |
Partial curl-ups | PM | 6-69 | 8-69 | |||||
Sit and reach | PM | 6-69 | 6-69 | 6-69 | 6-69 | |||
Musculoskeletal health | Peripheral quantitative computed tomography (pQCT) | PM | 6-79 | 6-79 | ||||
Mechanography (multiple 2 legged hopping) |
PM | 6-79 | 6-79 | 6-79Footnote 17 | ||||
Mechanography (single 2 legged jump) |
PM | 6-79 | 6-79 | 6-79Footnote 17 | ||||
Dual-energy x-ray absorptiometry (DXA) | PM | 1-79 | ||||||
Nutrition | Fish and shellfish consumption | Q | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 | |
Seaweed Consumption | Q | 1-79 | ||||||
Recent Consumption (48h) | 1-79 | |||||||
Oral health | Oral health examination | PM | 6-79 | |||||
Physical activity | Accelerometry (activity monitor)Footnote 6 | PM | 6-79Footnote 14 | 3-79Footnote 14 | 3-79Footnote 14 | 3-79Footnote 14 | 3-79Footnote 14 | 3-79Footnote 14 |
Specimen collectionFootnote 7,Footnote 8 | Blood collection | SC | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Urine collection | SC | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Home urine collectionFootnote 9 | SC | 3-79 | 3-79 | 3-79 | ||||
Saliva Collection | SC | 3-79 | 1-79 | |||||
Hair Sampling | SC | 20-59 | ||||||
Vision | Vision Questions | Q | 3-79 | 3-79 | ||||
Visual acuity | PM | 6-19,(20-39)Footnote 10, 40-79 | 6-19,(20-39)Footnote 10, 40-79 | |||||
Visual fieldFootnote 16 | PM | (20-39)Footnote 10, 40-79 | (20-39)Footnote 10, 40-79 | |||||
Retinal photographyFootnote 16 | PM | (20-39)Footnote 10, 40-79 | (20-39)Footnote 10,40-79 | |||||
Intraocular pressure | PM | (20-39)Footnote 10, 40-79 | (20-39)Footnote 10, 40-79 | |||||
Vitamin D | Skin pigmentation | PM | 3-79 | 3-79 | ||||
Sun Exposure | Q | 3-79 | 3-79 | 3-79 | ||||
|
Subject | Matrix | Cycle 1 2007-2009 |
Cycle 2 2009-2011 |
Cycle 3 2012-2013 |
Cycle 4 2014-2015 |
Cycle 5 2016-2017 |
Cycle 6 2018-2019 |
---|---|---|---|---|---|---|---|
Age (years) | |||||||
Total immunoglobulin E (IgE) | B | 6-79 | 6-79 |
Subject | Matrix | Cycle 1 2007-2009 |
Cycle 2 2009-2011 |
Cycle 3 2012-2013 |
Cycle 4 2014-2015 |
Cycle 5 2016-2017 |
Cycle 6 2018-2019 |
---|---|---|---|---|---|---|---|
Age (years) | |||||||
Procollagen type I N-terminal propeptide | B | 6-79 | 6-79 | ||||
Parathyroid hormone | B | 3-79 | 6-79 | 6-79 | |||
C-telopeptide of collagen type I | B | 6-79 Footnote 1 |
6-79 Footnote 1 |
||||
|
Subject | Matrix | Cycle 1 2007-2009 |
Cycle 2 2009-2011 |
Cycle 3 2012-2013 |
Cycle 4 2014-2015 |
Cycle 5 2016-2017 |
Cycle 6 2018-2019 |
---|---|---|---|---|---|---|---|
Age (years) | |||||||
Apolipoprotein A1 (ApoA1) | B | 6-79 Footnote 1 | 20-79 Footnote 1 | 20-79 Footnote 1 | 20-79 Footnote 1 | 20-79 Footnote 1 | |
Apolipoprotein B (ApoB) | B | 6-79 Footnote 1 |
20-79 Footnote 1 | 20-79 Footnote 1 | 20-79 Footnote 1 | 20-79 Footnote 1 | |
Fibrinogen | B | 12-79 | 12-79 | ||||
High density lipoprotein cholesterol (HDL-C) | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
High sensitivity C-reactive protein (HsCRP) | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Homocysteine | B | 6-79 | 3-79 | 3-79 | |||
Low density lipoprotein cholesterol (LDL-C): | |||||||
derived variable (Total cholesterol/High density lipoprotein-cholesterol ratio) | B | 6-79Footnote 1 | 6-79Footnote 1 | 6-79Footnote 1 | 6-79Footnote 1 | 6-79Footnote 1 | |
direct measure | B | 6-79Footnote 1 | |||||
Total cholesterol | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Triglycerides | B | 6-79Footnote 1 | 6-79Footnote 1 | 6-79Footnote 1 | 6-79Footnote 1 | 6-79Footnote 1 | 6-79Footnote 1 |
Red blood cell fatty acids: | |||||||
cis-monosaturated fatty acids: | B | 20-79 | 20-79 | ||||
cis-vaccenic acid | B | 20-79 | 20-79 | ||||
oleic acid | B | 20-79 | 20-79 | ||||
palmitoleic acid | B | 20-79 | 20-79 | ||||
omega 3 fatty acids: | B | 20-79 | 20-79 | ||||
alpha-linolenic acid | B | 20-79 | 20-79 | ||||
docosahexaenoic acid | B | 20-79 | 20-79 | ||||
n-3 docosapentaenoic acid | B | 20-79 | 20-79 | ||||
eicosapentaenoic acid | B | 20-79 | 20-79 | ||||
eicosatetraenoic acid | B | 20-79 | 20-79 | ||||
omega 6 fatty acids: | B | 20-79 | 20-79 | ||||
adrenic acid | B | 20-79 | 20-79 | ||||
arachidonic acid | B | 20-79 | 20-79 | ||||
dihomo-gamma-linolenic acid | B | 20-79 | 20-79 | ||||
n-6 docosapentaenoic acid | B | 20-79 | 20-79 | ||||
gamma-linolenic acid | B | 20-79 | 20-79 | ||||
linoleic acid | B | 20-79 | 20-79 | ||||
saturated fatty acids: | B | 20-79 | 20-79 | ||||
lauric acid | B | 20-79 | 20-79 | ||||
myristic acid | B | 20-79 | 20-79 | ||||
palmitic acid | B | 20-79 | 20-79 | ||||
stearic acid | B | 20-79 | 20-79 | ||||
trans fatty acids: | B | 20-79 | 20-79 | ||||
elaidic acid | B | 20-79 | 20-79 | ||||
palmitelaidic acid | B | 20-79 | 20-79 | ||||
trans-10 octadecenoic acid | B | 20-79 | 20-79 | ||||
trans-vaccenic acid | B | 20-79 | 20-79 | ||||
Red blood cell fatty acid calculated variables:
|
|||||||
alpha-Linolenic acid/Eicosapentaenoic acid | B | 20-79 | 20-79 | ||||
Arachidonic acid/Eicosapentaenoic acid | B | 20-79 | 20-79 | ||||
Eicosapentaenoic acid/Arachidonic acid | B | ||||||
Omega-3 index | B | 20-79 | 20-79 | ||||
Total 18:1 cis fatty acids | B | 20-79 | 20-79 | ||||
Total cis-monounsaturated fatty acids | B | 20-79 | 20-79 | ||||
Total n-3 PUFA | B | 20-79 | 20-79 | ||||
Total n-3 (18:4; 20:4; 20:5; 22:5; 22:6) | B | 20-79 | 20-79 | ||||
Total n-6 PUFA | B | 20-79 | 20-79 | ||||
Total n-6 (18:3; 20:3; 20:4; 22:4; 22:5) | B | 20-79 | 20-79 | ||||
Total n-6 PUFA/Total n-3 PUFA | B | 20-79 | 20-79 | ||||
Total n-6 LC-PUFA/ Total n-3 LC-PUFA | B | 20-79 | 20-79 | ||||
Total polyunsaturated fatty acids | B | 20-79 | 20-79 | ||||
Total saturated fatty acids | B | 20-79 | 20-79 | ||||
Total 18:1 trans fatty acids | B | 20-79 | 20-79 | ||||
Total 18:2 trans fatty acids | B | 20-79 | 20-79 | ||||
Total 18:3 trans fatty acids | B | 20-79 | 20-79 | ||||
Total trans fatty acids | B | 20-79 | 20-79 | ||||
|
Subject | Matrix | Cycle 1 2007-2009 |
Cycle 2 2009-2011 |
Cycle 3 2012-2013 |
Cycle 4 2014-2015 |
Cycle 5 2016-2017 |
Cycle 6 2018-2019 |
---|---|---|---|---|---|---|---|
Age (years) | |||||||
Alanine aminotransferase (ALT) | B | 6-79 | 3-79 | 3-79 | 3-79 | ||
Albumin | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Alkaline phosphatase (ALKP) | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Aspartate aminotransferase (AST) | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Bicarbonate (CO2) | B | 6-79 | |||||
Calcium | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Chloride | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Creatinine | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Gamma-glutamyl transferase (GGT) | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Lactate dehydrogenase (LD) | B | 6-79 | |||||
Magnesium | B | 3-79 | 3-79 | 3-79 | 3-79 | ||
Phosphorus | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Potassium | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Sodium | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Total bilirubin (TBIL) | B | 6-79 | 3-79 | ||||
Total protein (TP) | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Urea | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Uric Acid | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Subject | Matrix | Cycle 1 2007-2009 |
Cycle 2 2009-2011 |
Cycle 3 2012-2013 |
Cycle 4 2014-2015 |
Cycle 5 2016-2017 |
Cycle 6 2018-2019 |
---|---|---|---|---|---|---|---|
Age (years) | |||||||
Hemoglobin: | |||||||
hemoglobin | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
mean corpuscular hemoglobin | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
mean corpuscular hemoglobin concentration | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Platelets: | |||||||
mean platelet volume | B | 6-79 | 3-79 | ||||
platelet count | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Red blood cell: | |||||||
hematocrit | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
mean corpuscular volume | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
red cell distribution width | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
red blood cell count (RBC) | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
White blood cell: | |||||||
basophils | B | 6-79 | 3-79 | ||||
eosinophils | B | 6-79 | 3-79 | ||||
lymphocytes | B | 6-79 | 3-79 | ||||
neutrophils | B | 6-79 | 3-79 | ||||
monocytes | B | 6-79 | 3-79 | ||||
white blood cell count (WBC) | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Subject | Matrix | Cycle 1 2007-2009 |
Cycle 2 2009-2011 |
Cycle 3 2012-2013 |
Cycle 4 2014-2015 |
Cycle 5 2016-2017 |
Cycle 6 2018-2019 |
---|---|---|---|---|---|---|---|
Age (years) | |||||||
Glucose - plasma | B | 6-79 | |||||
Glucose - serum | B | 3-79 | 6-79Footnote 1 | 6-79Footnote 1 | 3-79 | 3-79 | |
Glycated hemoglobin A1c (HbA1c) | B | 6-79 | 6-79 | 6-79 | 6-79 | 6-79 | 6-79 |
Insulin | B | 6-79Footnote 1 | 6-79Footnote 1 | 6-79Footnote 1 | 6-79Footnote 1 | 6-79Footnote 1 | 6-79Footnote 1 |
|
Subject | Matrix | Cycle 1 2007-2009 |
Cycle 2 2009-2011 |
Cycle 3 2012-2013 |
Cycle 4 2014-2015 |
Cycle 5 2016-2017 |
Cycle 6 2018-2019 |
---|---|---|---|---|---|---|---|
Age (years) | |||||||
Microalbumin | U | 6-79 | 6-79 |
Subject | Matrix | Cycle 1 2007-2009 |
Cycle 2 2009-2011 |
Cycle 3 2012-2013 |
Cycle 4 2014-2015 |
Cycle 5 2016-2017 |
Cycle 6 2018-2019 |
---|---|---|---|---|---|---|---|
Age (years) | |||||||
Ferritin | B | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 | |
Iodine ((MEC)) | U | 6-79 | 3-79 | 3-79 | 3-79 | 3-19 (M), 3-39 (F) | 3-19 (M), 3-39 (F) |
Iodine (hhld visit) | U | 3-19 (M), 3-39 (F) | 3-19 (M), 3-39 (F) | ||||
Iodine/creatinine ratio (hhld & (MEC)) | U | 3-19 (M), 3-39 (F) | 3-19 (M), 3-39 (F) | ||||
Sodium (hhld & (MEC)) | U | 3-79 | 3-79 | ||||
Potassium (hhld & (MEC)) | U | 3-79 | 3-79 | ||||
Red blood cell folate | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Vitamin B12 | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Vitamin C (L-ascorbic acid) | B | 6-79Footnote 1 | |||||
Total Vitamin D3 [25-OH] - plasma | B | 6-79 | 3-79 | ||||
Vitamin D3 [25-OH] - serum | B | 3-79 | 3-79 | ||||
Vitamin D3 [3-epi-25-OH] - serum | B | 3-79 | 3-79 | ||||
Vitamin D2 [25-OH] - serum | B | 3-79 | 3-79 | ||||
Total Vitamin D [25(OH)] - serum | B | 3-79 | 3-79 | 3-79 | 3-79 | ||
|
Subject | Matrix | Cycle 1 2007-2009 |
Cycle 2 2009-2011 |
Cycle 3 2012-2013 |
Cycle 4 2014-2015 |
Cycle 5 2016-2017 |
Cycle 6 2018-2019 |
---|---|---|---|---|---|---|---|
Age (years) | |||||||
Estradiol (E2) | B | 6-79 | 6-79 | ||||
Follicle-stimulating hormone (FSH) | B | 6-79Footnote 3 (F) | 6-79Footnote 3 (F) | ||||
Luteinizing hormone (LH) | B | 6-79 (F) | 6-79Footnote 3 (F) | ||||
Progesterone (P4) | B | 6-79Footnote 3 (F) | 6-79Footnote 3 (F) | ||||
Testosterone | B | 6-79Footnote 3 (M) | 6-79Footnote 3 (M) | ||||
|
Subject | Matrix | Cycle 1 2007-2009 |
Cycle 2 2009-2011 |
Cycle 3 2012-2013 |
Cycle 4 2014-2015 |
Cycle 5 2016-2017 |
Cycle 6 2018-2019 |
---|---|---|---|---|---|---|---|
Age (years) | |||||||
anti-thyroglobulin | B | 3-79 | 3-79 | ||||
anti-thyroid peroxidase | B | 3-79 | 3-79 | ||||
free thyroxine | B | 3-79 | 3-79 | 3-79 | 3-79 | ||
thyroid stimulating hormone | B | 3-79 | 3-79 | 3-79 | 3-79 |
Subject | Matrix | Cycle 1 2007-2009 |
Cycle 2 2009-2011 |
Cycle 3 2012-2013 |
Cycle 4 2014-2015 |
Cycle 5 2016-2017 |
Cycle 6 2018-2019 |
---|---|---|---|---|---|---|---|
Age (years) | |||||||
Bisphenol A (BPA) | U | 6-79 | 3-79Footnote 2 | 3-79 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 |
Ethylene thiourea (ETU) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
ortho-phenylphenol (OPP) | U | ||||||
Ortho-phenylphenol glucuronide (OPP-G) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
Ortho-phenylphenol sulphate (OPP-S) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
Pooled serum organohalogens | B | 3-79 (P) | 3-79 (P) | 3-79 (P) | 3-79 (P) | ||
Triclocarban | U | 3-79Footnote 2 | |||||
Triclosan | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
Acrylamide: | |||||||
acrylamide hemoglobin adduct | B | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
glycidamide hemoglobin adduct | B | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
Benzene metabolites: | |||||||
tt-muconic acid | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
phenol | U | 3-79Footnote 2 | |||||
s-phenylmercapturic acid | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
Carbamate insecticides: | |||||||
carbofuranphenol | U | 3-79Footnote 2 | |||||
2-isopropoxyphenol | U | 3-79Footnote 2 | |||||
Chlorophenols: | |||||||
2,4-dichlorophenol (2,4-DCP) | U | 6-79 | 3-79Footnote 2 | ||||
2,5-dichlorophenol (2,5-DCP) | U | 3-79Footnote 2 | |||||
pentachlorophenol | U | 3-79Footnote 2 | |||||
2,4,5-trichlorophenol | U | 3-79Footnote 2 | |||||
2,4,6-trichlorophenol | U | 3-79Footnote 2 | |||||
Metals and trace elements: | |||||||
alumunium | H | 20-59 | |||||
antimony | U | 6-79 | 3-79 | ||||
antimony | H | 20-59 | |||||
arsenic (speciated): | |||||||
arsenobetaine/arsenocholine | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |
arsenocholine | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
arsenic (V) acid | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |
arsenous (III) acid | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |
dimethylarsinic acid | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |
monomethylarsonic acid | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |
Inorganic-related arsenic species | DV | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
arsenic (total) | B | 6-79 | |||||
arsenic (total) | U | 6-79 | 3-79 | ||||
arsenic (total) | H | 20-59 | |||||
barium | H | 20-59 | |||||
beryllium | H | 20-59 | |||||
bismuth | H | 20-59 | |||||
boron | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
cadmium | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
cadmium | U | 6-79 | 3-79 | 3-79Footnote 2 | 3-79Footnote 2 | ||
cadmium | H | 20-59 | |||||
cesium | U | 3-79 | |||||
chromium | H | 20-59 | |||||
cobalt | B | 3-79 | |||||
cobalt | U | 3-79 | |||||
cobalt | H | 20-59 | |||||
copper | B | 6-79 | 3-79 | ||||
copper | U | 6-79 | 3-79 | ||||
copper | H | 20-59 | |||||
fluoride | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
lead | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
lead | U | 6-79 | 3-79 | ||||
lead | H | 20-59 | |||||
lithium | H | 20-59 | |||||
manganese | B | 6-79 | 3-79 | ||||
manganese | U | 6-79 | 3-79 | ||||
manganese | H | 20-59 | |||||
mercury: | |||||||
inorganic | B | 6-79Footnote 2 | 3-19Footnote 2 | 3-19Footnote 2 | |||
inorganic | U | 6-79 | 3-79 | 3-79 | |||
methyl | B | 20-79Footnote 2 | 20-79Footnote 2 | 3-19Footnote 2 | 3-19Footnote 2 | ||
total | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
total | H | 20-59 | |||||
molybdenum | B | 6-79 | 3-79 | ||||
molybdenum | U | 6-79 | 3-79 | ||||
molybdenum | H | 20-59 | |||||
nickel | B | 6-79 | 3-79 | ||||
nickel | U | 6-79 | 3-79 | ||||
nickel | H | 20-59 | |||||
platinum | H | 20-59 | |||||
red blood cell chromium | B | 3-79Footnote 2 | 3-79Footnote 2 | ||||
selenium | B | 6-79 | 3-79 | 3-79 | 3-79 | ||
selenium | U | 6-79 | 3-79 | ||||
selenium | H | 20-59 | |||||
silver | B | 3-79 | |||||
silver | U | 3-79 | |||||
silver | H | 20-59 | |||||
tellurium | H | 20-59 | |||||
thallium | U | 3-79 | |||||
thallium | H | 20-59 | |||||
thorium | H | 20-59 | |||||
tungsten | U | 3-79 | |||||
uranium | B | 6-79 | 3-79 | ||||
uranium | U | 6-79 | 3-79 | ||||
uranium | H | ||||||
vanadium | U | 6-79 | 3-79 | ||||
vanadium | H | 20-59 | |||||
zinc | B | 6-79 | 3-79 | ||||
zinc | U | 6-79 | 3-79 | ||||
zinc | H | 0000 | 20-59 | ||||
Organochlorine pesticides: | |||||||
aldrin | B | 20-79Footnote 1Footnote 2 | |||||
alpha-chlordane | B | 20-79Footnote 1Footnote 2 | |||||
gamma-chlordane | B | 20-79Footnote 1Footnote 2 | |||||
cis-nonachlor | B | 20-79Footnote 1Footnote 2 | |||||
trans-nonachlor | B | 20-79Footnote 1Footnote 2 | |||||
oxychlordane | B | 20-79Footnote 1Footnote 2 | |||||
beta-hexachlorocyclohexane (ß-HCH) | B | 20-79Footnote 1Footnote 2 | |||||
gamma-hexachlorocyclohexane (γ-HCH) | B | 20-79Footnote 1Footnote 2 | |||||
hexachlorobenzene (HCB) | B | 20-79Footnote 1Footnote 2 | |||||
mirex | B | 20-79Footnote 1Footnote 2 | |||||
p,p'-dichlorodiphenyldichloroethylene (p,p'-DDE) | B | 20-79Footnote 1Footnote 2 | |||||
p,p'-dichlorodiphenyltrichloroethane (p,p'-DDT) | B | 20-79Footnote 1Footnote 2 | |||||
Toxaphene parlar 26 | B | 20-79Footnote 1Footnote 2 | |||||
Toxaphene parlar 50 | B | 20-79Footnote 1Footnote 2 | |||||
Organophosphate insecticides | |||||||
acephate | U | 3-79Footnote 2Footnote 5 | |||||
dimethylphosphate (DMP) | U | 6-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
dimethylthiophosphate (DMTP) | U | 6-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
dimethyldithiophosphate (DMDTP) | U | 6-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
diethylphosphate (DEP) | U | 6-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
diethylthiophosphate (DETP) | U | 6-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
diethyldithiophosphate (DEDTP) | U | 6-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
malathion dicarboxylic acid | U | 3-79Footnote 2Footnote 5 | 3-79Footnote 2 | ||||
methamidophos | U | 3-79Footnote 2Footnote 5 | |||||
3,5,6 trichloro-2-pyridinol | U | 3-79Footnote 2Footnote 5 | 3-79Footnote 2 | ||||
Parabens: | |||||||
butyl paraben | U | 3-79Footnote 2Footnote 5 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
ethyl paraben | U | 3-79Footnote 2Footnote 5 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
methylparaben | U | 3-79Footnote 2Footnote 5 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
propyl paraben | U | 3-79Footnote 2Footnote 5 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
Iso-butylparaben | U | ||||||
Perfluoroakyl substances: | |||||||
perfluorobutane sulfonate (PFBS) | B | 12-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
perfluorodecanoic acid (PFDA) | B | 12-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
perfluorohexane sulfonate (PFHxS) | B | 20-79 | 12-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
perfluorohexanoic acid (PFHxA) | B | 12-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
perfluoro-n-butyric acid (PFBA) | B | 12-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
perfluorononanoic acid (PFNA) | B | 12-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
perfluorooctane sulfonate (PFOS) | B | 20-79 | 12-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
perfluorooctanoic acid (PFOA) | B | 20-79 | 12-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
perfluoroundecanoic acid (PFUDA) | B | 12-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
Phenoxy Herbicide: | |||||||
2,4-dichlorophenoxyacetic acid (2,4-D) | U | 6-79 | 3-79Footnote 2 | ||||
Phthalate metabolites: | |||||||
mono benzyl phthalate (MBzP) | U | 6-49 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
mono-3-carboxypropyl phthalate (MCPP) | U | 6-49 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
mono-3-hydroxy-n-butyl phthalate (3OH-MBP) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
mono cyclohexyl phthalate (MCHP) | U | 6-49 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) | U | 6-49 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP) | U | 6-49 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
mono-2-ethylhexyl phthalate (MEHP) | U | 6-49 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
mono ethyl phthalate (MEP) | U | 6-49 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
mono-iso-butyl phthalate (MiBP) | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
mono-isononyl phthalate (MiNP) | U | 6-49 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
mono-n-butyl phthalate (MnBP) | U | 6-49 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
mono-n-octyl phthalate (MOP) | U | 6-49 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
mono-methyl phthalate (MMP) | U | 6-49 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
mono-carboxy-n-heptyl phthalate (MCHpP) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
mono-(2-ethyl-5-carboxypentyl) phthalate (MECPP) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
mono-(2-carboxymethylhexyl) phthalate (MCMHP) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
mono-(carboxyisooctyl) phthalate (MCIOP) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
mono-(oxoisononyl) phthalate (MOINP) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
mono-(hydroxyisononyl) phthalate (MHINP) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
monocarboxyisononyl phthalate (MCiNP) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
mono-isodecyl phthalate (MIDP) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
monooxoisodecyl phthalate (MOiDP) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
monohydroxyisodecyl phthalate (MHiDP) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
Polyaromatic hydrocarbons: | |||||||
chrysenes: | |||||||
2-hydroxychrysene | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
3-hydroxychrysene | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
4-hydroxychrysene | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
6-hydroxychrysene | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
fluoranthene: | |||||||
3-hydroxyfluoranthene | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
fluorenes: | |||||||
2-hydroxyfluorene | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
3-hydroxyfluorene | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
9-hydroxyfluorene | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
napthalenes: | |||||||
1-hydroxynaphthol | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
2-hydroxynaphthol | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
phenanthrenes: | |||||||
1-hydroxyphenanthrene | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
2-hydroxyphenanthrene | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
3-hydroxyphenanthrene | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
4-hydroxyphenanthrene | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
9-hydroxyphenanthrene | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
pyrene: | |||||||
3-hydroxybenzo(a)pyrène | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
1-hydroxypyrene | U | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | |||
Alternate plasticizers | |||||||
mono-isononyl-cyclohexane-1,2-dicarboxylate (MINCH) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
1,2-(trans-cyclohexane-dicarboxylate)-mono-(7-carboxylate-4-methyl) heptyl ester (trans-cx-MINCH) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
1,2-(cis-cyclohexane-dicarboxylate)-mono-(7-carboxylate-4-methyl) heptyl ester (cis-cx-MINCH) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
cis-cyclohexane-1,2-dicarboxylic acid (cis-CHDA) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
1,2-(cyclohexane-dicarboxylate)-mono-(7-hydroxy-4-methyl) octyl ester (OH-MINCH) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
1,2-(cyclohexane-dicarboxylate)-mono-(7-oxo-4-methyl) octyl ester (oxo-MINCH) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
1,2-(trans-cyclohexane-dicarboxylate)-mono-4-methyloctyl ester (trans-MINCH) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
2,2,4-trimethyl-1,2-pentanediol (TMPD) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
2,2,4-trimethyl-3-hydroxy valeric acid (HTMV) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
1,2,4-benzenetricarboxylate 1-(2-ethylhexyl) ester (1-MEHTM) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
1,2,4-benzenetricarboxylate 2-(2-ethylhexyl) ester (2-MEHTM) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
1,2,4-benzenetricarboxylate 4-(2-ethylhexyl) ester (4-MEHTM) | U | 3-79Footnote 2 | 3-79Footnote 2 | ||||
Polybrominated flame retardants: | |||||||
Polybrominated biphenyls 153 (PBB 153) | B | 20-79Footnote 1Footnote 2 | |||||
Polybrominated diphenyl ether (PBDE) 15, 17, | B | 20-79Footnote 1Footnote 2 | |||||
PBDE 25, 28, 33, 47, 99, 100, 153 | B | 20-79Footnote 1Footnote 2 | |||||
Polychlorinated biphenyls (PCBs): | |||||||
Aroclor 1260 | B | 20-79Footnote 1Footnote 2 | |||||
PCB 28, 52, 66, 74, 99, 101, 105, 118, | B | 20-79Footnote 1Footnote 2 | |||||
PCB 128, 138, 146, 153, 156, 163, 167, 170, | B | 20-79Footnote 1Footnote 2 | |||||
PCB 178, 180, 183, 187, 194, 201, 203, 206 | B | 20-79Footnote 1Footnote 2 | |||||
Pyrethroids pesticides: | |||||||
cis-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DBCA) | U | 6-79 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
cis-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DCCA) | U | 6-79 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
4-fluoro-3-phenoxybenzoic acid (4-F-3-PBA) | U | 6-79 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
3-phenoxybenzoic acid (3-PBA) | U | 6-79 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (trans-DCCA) | U | 6-79 | 3-79Footnote 2 | 3-79Footnote 2 | 3-79Footnote 2 | ||
Tobacco: | |||||||
nicotine and metabolites: | |||||||
anabasine | U | 12-79Footnote 2 | 12-79 | 12-79 | |||
free cotinine | U | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 6-79Footnote 2 |
free cotinine | S | 6-79 | |||||
total cotinine | U | 12-79Footnote 2 | |||||
cotinine-n-glucuronide | U | 12-79Footnote 2 | 12-79 | 12-79 | |||
nicotine | U | 12-79Footnote 2 | 12-79 | 12-79 | |||
nicotine-n-glucuronide | U | 12-79Footnote 2 | 12-79 | 12-79 | |||
trans-3-hydroxycotinine free | U | 12-79Footnote 2 | 12-79 | 12-79 | 12-79Footnote 2 | ||
trans-3-hydroxycotinine-O-glucuronide | U | 12-79Footnote 2 | 12-79 | 12-79 | |||
NNK metabolites (4-(methyl-nitrosamino)-1-butanone): | |||||||
free NNAL | U | 12-79Footnote 2 | 12-79Footnote 2 | 12-79Footnote 2 | |||
total NNAL | U | 12-79Footnote 2 | 12-79Footnote 2 | 12-79Footnote 2 | 6-79Footnote 2 | ||
Triazine herbicides: | |||||||
atrazine mercapturate | U | 3-79Footnote 2 | |||||
desethylatrazine | U | 3-79Footnote 2 | |||||
diaminochlorotriazine | U | 3-79Footnote 2 | |||||
Volatile organic compounds: | |||||||
common fuel pollutants (BTEX): | |||||||
benzene | B | 12-79Footnote 2 | 12-79Footnote 2 | 12-79Footnote 2 | |||
ethylbenzene | B | 12-79Footnote 2 | 12-79Footnote 2 | 12-79Footnote 2 | |||
m- & p-xylenes | B | 12-79Footnote 2 | 12-79Footnote 2 | 12-79Footnote 2 | |||
o-xylene | B | 12-79Footnote 2 | 12-79Footnote 2 | 12-79Footnote 2 | |||
toluene | B | 12-79Footnote 2 | 12-79Footnote 2 | 12-79Footnote 2 | |||
trihalomethanes: | |||||||
bromodichloromethane | B | 12-79Footnote 2 | 12-79Footnote 2 | 12-79Footnote 2 | |||
dibromochloromethane | B | 12-79Footnote 2 | 12-79Footnote 2 | 12-79Footnote 2 | |||
tribromomethane | B | 12-79Footnote 2 | 12-79Footnote 2 | 12-79Footnote 2 | |||
trichloromethane | B | 12-79Footnote 2 | 12-79Footnote 2 | 12-79Footnote 2 | |||
halogenated solvents: | |||||||
carbon tetrachloride | B | 12-79Footnote 2 | |||||
trichloroethylene | B | 12-79Footnote 2 | 12-79Footnote 2 | 12-79Footnote 2 | |||
tetrachloroethylene | B | 12-79Footnote 2 | 12-79Footnote 2 | 12-79Footnote 2 | |||
1,1,1,2-tetrachloroethane | B | 12-79Footnote 2 | |||||
benzenes: | |||||||
Isopropylbenzene | B | 12-79Footnote 2 | |||||
Nitrobenzene | B | 12-79Footnote 2 | |||||
1,4-dichlorobenzene | B | 12-79Footnote 2 | |||||
other: | |||||||
4-Methyl-2-pentanone | B | 12-79Footnote 2 | |||||
styrene | B | 12-79Footnote 2 | 12-79Footnote 2 | 12-79Footnote 2 | |||
furans: | |||||||
Tetrahydrofuran | B | 12-79 | |||||
2,5-dimethylfuran | B | 12-79 | |||||
Bisphenol analogues | |||||||
Bisphenol AF | U | ||||||
Bisphenol S | U | ||||||
Bisphenol F | U | ||||||
Bisphenol B | U | ||||||
Bisphenol E | U | ||||||
Bisphenol Z | U | ||||||
Bisphenol 4-4' (BP4) | U | ||||||
Flame retardants: BDEs | |||||||
2-Ethyl-1-hexyl 2,3,4,5-tetrabromobenzoate (EHTBB) or (TBB) | B | ||||||
bis(2-ethylhexyl) tetrabromophthalate (TBPH) | B | ||||||
pentabromoethylbenzene (PBEB) | B | ||||||
5-hydroxy-2,2',4,4'-tetrabromodiphenyl ether (5-OH-BDE-47) | B | ||||||
6-hydroxy-2,2',4,4'-tetrabromodiphenyl ether (6-OH-BDE-47) | B | ||||||
6-methoxy-2,2',4,4'-tetrabromodiphenyl ether (6-MeO-BDE-47) | B | ||||||
4'-hydroxy-2,2',4,5'- tetrabromodiphenyl ether (4'-OH-BDE-49) | B | ||||||
2,2',4,4'-Tetrabromodiphenyl ether (PBDE 47) | B | ||||||
2,2',4,4',5-Pentabromodiphenyl ether (PBDE 99) | B | ||||||
2,2',4,4',6-Pentabromodiphenyl ether (PBDE 100) | B | ||||||
2,2',4,4',5,5'-Hexabromodiphenyl ether (PBDE 153) | B | ||||||
Short-chained chlorinated paraffins (SCCPs) | B | ||||||
Total short chain (C10-C13) | B | ||||||
Congener C10H18Cl4 | B | ||||||
Congener C10H17Cl5 | B | ||||||
Congener C10H16Cl6 | B | ||||||
Congener C10H15Cl7 | B | ||||||
Congener C10H14Cl8 | B | ||||||
Congener C10H13Cl9 | B | ||||||
Congener C11H20Cl4 | B | ||||||
Congener C11H18Cl6 | B | ||||||
Congener C11H16C8 | B | ||||||
Congener C12H20Cl6 | B | ||||||
Congener C12H18C8 | B | ||||||
Congener C13H24Cl4 | B | ||||||
Congener C13H22Cl6 | B | ||||||
Congener C13H20Cl8 | B | ||||||
Total medium chain (C14-C17) | B | ||||||
Congener C14H22Cl8 | B | ||||||
Congener C15H22Cl6 | B | ||||||
Congener C16H26Cl8 | B | ||||||
Congener C17H28Cl8 | B | ||||||
Flame retardants: OP | |||||||
Bis-2(butoxyethyl) phosphate (BBOEP) | U | ||||||
Bis(2-chloropropyl) phosphate (BCIPP) | U | ||||||
Bis(1,3-dichloro-2-propyl) phosphate (BDCIPP) |
U | ||||||
Diphenyl phosphate (DPHP) | U | ||||||
Di-o-cresyl phosphate or Di-o-tolyl phosphate (DoCP) | U | ||||||
Di-p-cresyl phosphate or Di-p-tolyl-phosphate (DpCP) | U | ||||||
Food additives | |||||||
3,5-di-tert-butyl-4-hydroxybenzoic acid (BHT-acid) | U | ||||||
Polycyclic musks | |||||||
7-Acetyl-1,1,3,4,4,6-hexamethyltetrahydronaphthalene [1-(5,6,7,8-Tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthalenyl)ethanone] (AHTN, Tonalide) |
B | ||||||
1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta[g]-2-benzopyran (HHCB, Galaxolide) | B | ||||||
UV-related compounds | |||||||
2,4-dihydroxybenzophenone (Benzophenone-1) | U | ||||||
2,2',4,4'-tetrahydroxybenzophenone (Benzophenone-2) | U | ||||||
2-hydroxy-4-methoxybenzophenone (Benzophenone-3) | U | ||||||
2,2'-dihydroxy-4-methoxybenzophenone (Benzophenone-8) | U | ||||||
4-hydroxybenzophnenone (4-OH-Benzophenone) | U | ||||||
2-Ethyl-hexyl-4-methoxycinnamate (Octinoxate; Octylmethoxycinnamate) | U | ||||||
3-(4-methylbenzylidene)-camphor (enzacamene; 4-MBC) | U | ||||||
N,N-dimethyl-p-aminobenzoic acid (DMP) | U | ||||||
N-monomethyl-p-aminobenzoic acid (MMP) | U | ||||||
Pesticides: DEET and IMPY | |||||||
N,N-Diethyl-m-toluamide (DEET) | U | ||||||
m-[(N,N-diethylamino)carbonyl] benzoic acid (DCBA) | U | ||||||
N,N-Diethyl-m-hydroxymethylbenzamide (DHMB) | U | ||||||
2-isopropyl-4-methyl-6-hydroxypyrimidine (IMPY) | U | ||||||
Pesticides: Glyphosate and Glufosinate | |||||||
Glyphosate (GLYPH) | U | ||||||
Aminomethylphosphonic acid (AMPA) | U | ||||||
Glufosinate (GLUF) (or glufosinate ammonium) | U | ||||||
3-Methylphosphinico propionicacid(3-MPPA) | U | ||||||
Pesticides: Neonicotinoids | |||||||
5-Hydroxyimidacloprid | U | ||||||
N-Desmethylacetamiprid | U | ||||||
Acetamiprid (NXL) | U | ||||||
Clothianidin (CTH) | U | ||||||
Dinotefuran (DTQ) | U | ||||||
Imidacloprid (ICP) | U | ||||||
Nitenpyram (NTM) | U | ||||||
Thiacloprid (TAP) | U | ||||||
Thiamethoxam (THM) | U | ||||||
(P) = Pooled Serum
|
Subject | Matrix | Cycle 1 2007-2009 |
Cycle 2 2009-2011 |
Cycle 3 2012-2013 |
Cycle 4 2014-2015 |
Cycle 5 2016-2017 |
Cycle 6 2018-2019 |
---|---|---|---|---|---|---|---|
Age (years) | |||||||
Specific gravity | U | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 | |
Creatinine (hhld & (MEC)) | U | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Subject | Matrix | Cycle 1 2007-2009 |
Cycle 2 2009-2011 |
Cycle 3 2012-2013 |
Cycle 4 2014-2015 |
Cycle 5 2016-2017 |
Cycle 6 2018-2019 |
---|---|---|---|---|---|---|---|
Age (years) | |||||||
Hepatitis A virus antibody | B | 14-79 | |||||
Hepatitis B surface antigen | B | 14-79 | 14-79 | 14-79 | 14-79 | ||
Hepatitis B virus surface antibody | B | 14-79 | 14-79 | 14-79 | |||
Hepatitis B virus surface antigen | B | 14-79 | 14-79 | 14-79 | 14-79 | ||
Hepatitis C virus antibody | B | 14-79 | 14-79 | 14-79 | 14-79 | ||
Hepatitis C RNA | B | 14-79Footnote 4 | 14-79Footnote 4 | ||||
Chlamydia trachomatis | U | 14-59 | 14-59 | 14-59 | |||
Herpes simplex-2 | B | 14-59 | |||||
Human Papillomavirus | U | 14-59 | |||||
Anti-Toxoplasmosis | B | 3-79 | |||||
|
Subject | Matrix | Cycle 1 2007-2009 |
Cycle 2 2009-2011 |
Cycle 3 2012-2013 |
Cycle 4 2014-2015 |
Cycle 5 2016-2017 |
Cycle 6 2018-2019 |
||
---|---|---|---|---|---|---|---|---|---|
Age (years) | |||||||||
Acetone | IAS | 3-79 | 3-79 | 3-79 | |||||
a-Pinene | IAS | 3-79 | 3-79 | 3-79 | |||||
Benzaldehyde | IAS | 3-79 | 3-79 | 3-79 | |||||
Benzene | IAS | 3-79 | 3-79 | 3-79 | |||||
Benzenepropanol | IAS | 3-79 | |||||||
Benzofuran | IAS | 3-79 | 3-79 | ||||||
Biphenyl | IAS | 3-79 | |||||||
1-Bromodecane | IAS | 3-79 | 3-79 | ||||||
Bromodichloromethane | IAS | 3-79 | 3-79 | 3-79 | |||||
Tribromomethane | IAS | 3-79 | 3-79 | 3-79 | |||||
1-Bromooctane | IAS | 3-79 | 3-79 | ||||||
1-Bromopropane | IAS | 3-79 | 3-79 | ||||||
1-Butanol | IAS | 3-79 | 3-79 | 3-79 | |||||
2-Butanone | IAS | 3-79 | 3-79 | 3-79 | |||||
2-Butoxyethanol | IAS | 3-79 | 3-79 | 3-79 | |||||
Butyl ester benzoic acid | IAS | 3-79 | |||||||
Camphene | IAS | 3-79 | 3-79 | 3-79 | |||||
Carbon tetrachloride | IAS | 3-79 | |||||||
Chlorobenzene | IAS | 3-79 | 3-79 | ||||||
1-Chlorododecane | IAS | 3-79 | 3-79 | ||||||
Trichloromethane | IAS | 3-79 | 3-79 | 3-79 | |||||
Chloromethylbenzene | IAS | 3-79 | 3-79 | 3-79 | |||||
4-Chloro,3-methylphenol | IAS | 3-79 | |||||||
3-Chloropropene | IAS | 3-79 | |||||||
Cyclohexane | IAS | 3-79 | 3-79 | 3-79 | |||||
Cyclohexanol | IAS | 3-79 | 3-79 | 3-79 | |||||
Cyclohexanone | IAS | 3-79 | 3-79 | 3-79 | |||||
Decamethylcyclopentasiloxane | IAS | 3-79 | 3-79 | 3-79 | |||||
Decamethyltetrasiloxane | IAS | 3-79 | 3-79 | ||||||
Decanal | IAS | 3-79 | 3-79 | 3-79 | |||||
Decane | IAS | 3-79 | 3-79 | 3-79 | |||||
Dibromochloromethane | IAS | 3-79 | 3-79 | 3-79 | |||||
1,2-Dibromoethane | IAS | 3-79 | 3-79 | 3-79 | |||||
1,2-Dichlorobenzene | IAS | 3-79 | 3-79 | 3-79 | |||||
1,4-Dichlorobenzene | IAS | 3-79 | 3-79 | 3-79 | |||||
1,1-Dichloroethane | IAS | 3-79 | 3-79 | ||||||
1,2-Dichloroethane | IAS | 3-79 | 3-79 | ||||||
2,4-/2,5-dichlorotoluene | IAS | 3-79 | |||||||
1,3-Dichloro-2-propanol | IAS | 3-79 | 3-79 | ||||||
1,2-dichloropropane | IAS | 3-79 | |||||||
2,3-dichloropropene | IAS | 3-79 | |||||||
1,2-Dimethoxyethane | IAS | 3-79 | 3-79 | ||||||
Dimethoxymethane | IAS | 3-79 | |||||||
1,2-Dimethoxy-4-(2-propenyl)benzene | IAS | 3-79 | |||||||
Dimethyl ester pentanedioc acid | IAS | 3-79 | 3-79 | ||||||
2,5-Dimethylfuran | IAS | 3-79 | 3-79 | ||||||
1,4-Dioxane | IAS | 3-79 | 3-79 | 3-79 | |||||
Dodecamethylcyclohexasiloxane | IAS | 3-79 | |||||||
Dodecamethylpentasiloxane | IAS | 3-79 | 3-79 | ||||||
Dodecane | IAS | 3-79 | 3-79 | 3-79 | |||||
Ethanediol diacetate | IAS | 3-79 | |||||||
1-Ethenylpyrrolidinone | IAS | 3-79 | |||||||
2-(2-Ethoxyethoxy)ethanol | IAS | 3-79 | |||||||
2-Ethoxyethyl acetate | IAS | 3-79 | |||||||
Ethylbenzene | IAS | 3-79 | 3-79 | 3-79 | |||||
Ethyl ester benzoic acid | IAS | 3-79 | |||||||
2-Ethyl-1-hexanol | IAS | 3-79 | 3-79 | 3-79 | |||||
2-Furancarboxaldehyde | IAS | 3-79 | 3-79 | 3-79 | |||||
Heptanal | IAS | 3-79 | 3-79 | ||||||
Heptane | IAS | 3-79 | 3-79 | 3-79 | |||||
1,1,2,3,4,4-Hexachloro-1,3-butadiene | IAS | 3-79 | 3-79 | ||||||
Hexachloroethane | IAS | 3-79 | 3-79 | 3-79 | |||||
Hexamethyldisiloxane | IAS | 3-79 | 3-79 | ||||||
Hexanal | IAS | 3-79 | 3-79 | 3-79 | |||||
Hexane | IAS | 3-79 | 3-79 | 3-79 | |||||
2-Hexanone | IAS | 3-79 | 3-79 | ||||||
Limonene | IAS | 3-79 | 3-79 | 3-79 | |||||
2-Methoxyethyl acetate | IAS | 3-79 | |||||||
2-(2-Methoxyethoxy)ethanol | IAS | 3-79 | |||||||
2-Methyl-1,3-butadiene | IAS | 3-79 | 3-79 | 3-79 | |||||
Methyl ester benzoic acid | IAS | 3-79 | |||||||
Methyl ester hexanoic acid | IAS | 3-79 | |||||||
1-Methylethylbenzene | IAS | 3-79 | 3-79 | 3-79 | |||||
5-Methyl-2-hexanone | IAS | 3-79 | 3-79 | 3-79 | |||||
4-Methyl-2-pentanone | IAS | 3-79 | 3-79 | 3-79 | |||||
4-Methylpenten-2-one | IAS | 3-79 | |||||||
2-Methyl-2-propanol | IAS | 3-79 | 3-79 | 3-79 | |||||
2-Methylpropyl ester benzoic acid | IAS | 3-79 | |||||||
1-Methylpyrrolidinone | IAS | 3-79 | |||||||
Naphthalene | IAS | 3-79 | 3-79 | 3-79 | |||||
Nitromethane | IAS | 3-79 | |||||||
1-Nitropropane | IAS | 3-79 | |||||||
2-Nitropropane | IAS | 3-79 | |||||||
2-nitrotoluene | IAS | 3-79 | |||||||
Nonanal | IAS | 3-79 | 3-79 | 3-79 | |||||
Nonane | IAS | 3-79 | 3-79 | ||||||
Nonanol | IAS | 3-79 | |||||||
Octamethylcyclotetrasiloxane | IAS | 3-79 | 3-79 | 3-79 | |||||
Octamethyltrisiloxane | IAS | 3-79 | 3-79 | ||||||
Octanal | IAS | 3-79 | 3-79 | 3-79 | |||||
Octane | IAS | 3-79 | 3-79 | ||||||
Octanol | IAS | 3-79 | |||||||
Pentachloroethane | IAS | 3-79 | 3-79 | ||||||
Pentane | IAS | 3-79 | 3-79 | 3-79 | |||||
1-Pentanol | IAS | 3-79 | 3-79 | 3-79 | |||||
Pentanone | IAS | 3-79 | |||||||
2-Pentanone | IAS | 3-79 | 3-79 | ||||||
Perchloroethylene | IAS | 3-79 | 3-79 | 3-79 | |||||
Phenol | IAS | 3-79 | 3-79 | ||||||
1-Propanol | IAS | 3-79 | |||||||
2-Propanol | IAS | 3-79 | 3-79 | 3-79 | |||||
Quinoline | IAS | 3-79 | 3-79 | 3-79 | |||||
Styrene | IAS | 3-79 | 3-79 | 3-79 | |||||
1,1,1,2-Tetrachloroethane | IAS | 3-79 | 3-79 | ||||||
Tetrahydrofuran | IAS | 3-79 | 3-79 | 3-79 | |||||
Toluene | IAS | 3-79 | 3-79 | 3-79 | |||||
1,2,3-Trichlorobenzene | IAS | 3-79 | 3-79 | ||||||
1,2,4-Trichlorobenzene | IAS | 3-79 | 3-79 | ||||||
1,3,5-Trichlorobenzene | IAS | 3-79 | 3-79 | ||||||
1,1,2-Trichloroethane | IAS | 3-79 | 3-79 | ||||||
Trichloroethylene | IAS | 3-79 | |||||||
1,2,3-Trichloropropane | IAS | 3-79 | 3-79 | ||||||
1,2,3-Trimethylbenzene | IAS | 3-79 | 3-79 | 3-79 | |||||
1,2,4-trimethylbenzene | IAS | 3-79 | 3-79 | 3-79 | |||||
1,3,5-Trimethylbenzene | IAS | 3-79 | 3-79 | ||||||
3,5,5-Trimethyl-2-cyclohexen-1-one | IAS | 3-79 | |||||||
Undecane | IAS | 3-79 | 3-79 | 3-79 | |||||
o-Xylene | IAS | 3-79 | 3-79 | 3-79 | |||||
m,p-Xylene | IAS | 3-79 | 3-79 | 3-79 |
Subject | Matrix | Cycle 1 2007-2009 |
Cycle 2 2009-2011 |
Cycle 3 2012-2013 |
Cycle 4 2014-2015 |
Cycle 5 2016-2017 |
Cycle 6 2018-2019 |
---|---|---|---|---|---|---|---|
Age (years) | |||||||
Fluoride | TWS | 3-79 | 3-79 | ||||
Volatile organic compounds | |||||||
Common fuel pollutants (BTEX) | |||||||
Benzene | TWS | 3-79 | 3-79 | ||||
Ethylbenzene | TWS | 3-79 | 3-79 | ||||
m- & p-Xylenes | TWS | 3-79 | 3-79 | ||||
o-Xylene | TWS | 3-79 | 3-79 | ||||
Toluene | TWS | 3-79 | 3-79 | ||||
Total xylene | TWS | 3-79 | 3-79 | ||||
Trihalomethanes | |||||||
Bromodichloromethane | TWS | 3-79 | 3-79 | ||||
Dibromochloromethane | TWS | 3-79 | 3-79 | ||||
Tribromomethane | TWS | 3-79 | 3-79 | ||||
Trichloromethane | TWS | 3-79 | 3-79 | ||||
Metals and trace elements in water | |||||||
Antimony (Sb) | TWS | ||||||
Arsenic (total) (As) | TWS | ||||||
Beryllium (Be) | TWS | ||||||
Boron (Bo) | TWS | ||||||
Cadmium (Cd) | TWS | ||||||
Chromium (Cr) | TWS | ||||||
Cobalt (Co) | TWS | ||||||
Copper (Cu) | TWS | ||||||
Lead (Pb) | TWS | ||||||
Manganese (Mn) | TWS | ||||||
Molybdenum (Mo) | TWS | ||||||
Nickel (Ni) | TWS | ||||||
Selenium (Se) | TWS | ||||||
Silver (Ag) | TWS | ||||||
Uranium (Ur) | TWS | ||||||
Zinc (Zn) | TWS |
Subject | Matrix | Cycle 1 2007-2009 |
Cycle 2 2009-2011 |
Cycle 3 2012-2013 |
Cycle 4 2014-2015 |
Cycle 5 2016-2017 |
Cycle 6 2018-2019 |
---|---|---|---|---|---|---|---|
Age (years) | |||||||
DNA Storage | B/S | 20-79 | 20-79 | 14-79 | 14-79 | 3-79 | 3-79 |
Buffy Coat Storage | Buf | ||||||
Urine Storage | U | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Plasma Storage | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Whole Blood Storage | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
Serum Storage | B | 6-79 | 3-79 | 3-79 | 3-79 | 3-79 | 3-79 |
|